Bruzzi P - Search Results

1

Hematologic parameters during treatment with high-dose medroxyprogesterone acetate.

Brema F, Queirolo MA, Canobbio L, Bruzzi P, Puntoni R, Campora E, Rosso R. Brema F, et al. Among authors: bruzzi p. Tumori. 1981 Mar-Apr;67(2):125-8. doi: 10.1177/030089168106700208. Tumori. 1981. PMID: 6454998

2

The antiemetic efficacy of methylprednisolone compared with metoclopramide in outpatients receiving adjuvant CMF chemotherapy for breast cancer: a randomized trial.

Campora E, Chiara S, Bruzzi P, Scarsi P, Rosso R. Campora E, et al. Among authors: bruzzi p. Tumori. 1985 Oct 31;71(5):459-62. doi: 10.1177/030089168507100508. Tumori. 1985. PMID: 3904102 Clinical Trial.

3

Hypercoagulable state induced by cytostatic drugs in stage II breast cancer patients.

Canobbio L, Fassio T, Ardizzoni A, Bruzzi P, Queirolo MA, Zarcone D, Di Giorgio F, Rosso R, Santi L. Canobbio L, et al. Among authors: bruzzi p. Cancer. 1986 Sep 1;58(5):1032-6. doi: 10.1002/1097-0142(19860901)58:5<1032::aid-cncr2820580509>3.0.co;2-u. Cancer. 1986. PMID: 3731037

4

Methylprednisolone for the control of CMF-induced emesis.

Chiara S, Campora E, Lionetto R, Bruzzi P, Rosso R. Chiara S, et al. Among authors: bruzzi p. Am J Clin Oncol. 1987 Jun;10(3):264-7. doi: 10.1097/00000421-198706000-00021. Am J Clin Oncol. 1987. PMID: 3296735 Clinical Trial.

5

The role of vindesine and lonidamine in the treatment of elderly patients with advanced non-small cell lung cancer: a phase III randomized FONICAP trial. Italian Lung Cancer Task Force.

De Marinis F, Rinaldi M, Ardizzoni A, Bruzzi P, Pennucci MC, Portalone L, D'Aprile M, Ripanti P, Romano F, Belli M, Altavilla G, Migliorino MR, Rosso R, Salvati F. De Marinis F, et al. Among authors: bruzzi p. Tumori. 1999 May-Jun;85(3):177-82. doi: 10.1177/030089169908500306. Tumori. 1999. PMID: 10426128 Clinical Trial.

6

Low-dose metoclopramide versus methylprednisolone in controlling chemotherapy induced nausea and vomiting.

Chiara S, Scarsi P, Campora E, Bruzzi P, Tatarek R, Rosso R. Chiara S, et al. Among authors: bruzzi p. Chemioterapia. 1984 Oct;3(5):333-6. Chemioterapia. 1984. PMID: 6398127 Clinical Trial.

7

Double-blind randomized trial of lorazepam versus placebo with methylprednisolone for control of emesis due to non-cisplatin containing chemotherapy.

Campora E, Baldini E, Rubagotti A, Chiara S, Bruzzi P, Sertoli MR, Rosso R. Campora E, et al. Among authors: bruzzi p. J Chemother. 1990 Oct;2(5):336-9. doi: 10.1080/1120009x.1990.11739039. J Chemother. 1990. PMID: 2090773 Clinical Trial.

8

Estrogen-like action of tamoxifen on vaginal epithelium in breast cancer patients.

Boccardo F, Bruzzi P, Rubagotti A, Nicolò GU, Rosso R. Boccardo F, et al. Among authors: bruzzi p. Oncology. 1981;38(5):281-5. doi: 10.1159/000225571. Oncology. 1981. PMID: 7266969

9

Long-term prognosis following macroscopic complete response at second-look laparotomy in advanced ovarian cancer patients treated with platinum-based chemotherapy. The Gruppo Oncologico Nord Ovest.

Chiara S, Lionetto R, Campora E, Oliva C, Merlini L, Bruzzi P, Rosso R, Conte PF. Chiara S, et al. Among authors: bruzzi p. Eur J Cancer. 1995;31A(3):296-301. doi: 10.1016/0959-8049(94)00487-p. Eur J Cancer. 1995. PMID: 7786592 Clinical Trial.

10

High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer.

Ardizzoni A, Venturini M, Crinò L, Sertoli MR, Bruzzi P, Pennucci MC, Mariani GL, Garrone O, Bracarda S, Rosso R, et al. Ardizzoni A, et al. Among authors: bruzzi p. Eur J Cancer. 1993;29A(5):687-92. doi: 10.1016/s0959-8049(05)80347-8. Eur J Cancer. 1993. PMID: 8385970

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

394 results

Search Page